Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:BAR NYSE:CRL NASDAQ:REVB NASDAQ:SKIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBARGraniteShares Gold Trust$33.51-0.1%$33.05$23.91▼$34.04$1.14B0.15768,182 shs2.65 million shsCRLCharles River Laboratories International$149.07-0.5%$155.55$91.86▼$230.02$7.32B1.48961,128 shs663,865 shsREVBRevelation Biosciences$2.38-6.7%$2.58$2.11▼$168.00$3.65M-0.06223,451 shs206,164 shsSKINBeauty Health$1.89+18.9%$1.77$0.78▼$2.38$238.13M1.21.15 million shs7.71 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBARGraniteShares Gold Trust0.00%+1.24%+2.20%+2.10%+42.29%CRLCharles River Laboratories International0.00%-10.68%-8.90%+7.37%-25.45%REVBRevelation Biosciences0.00%-2.46%-15.90%-75.05%-95.32%SKINBeauty Health0.00%+23.53%-7.35%+3.31%+51.20%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBARGraniteShares Gold TrustN/AN/AN/AN/AN/AN/AN/AN/ACRLCharles River Laboratories International4.6413 of 5 stars3.14.00.04.72.72.51.9REVBRevelation Biosciences0.2668 of 5 stars0.02.00.00.00.80.01.3SKINBeauty Health1.7429 of 5 stars3.00.00.00.03.33.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBARGraniteShares Gold Trust 0.00N/AN/AN/ACRLCharles River Laboratories International 2.27Hold$175.6917.86% UpsideREVBRevelation Biosciences 0.00N/AN/AN/ASKINBeauty Health 2.00Hold$2.6338.89% UpsideCurrent Analyst Ratings BreakdownLatest BAR, SKIN, CRL, and REVB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025CRLCharles River Laboratories InternationalEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$180.00 ➝ $190.008/7/2025CRLCharles River Laboratories InternationalJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$145.00 ➝ $160.008/7/2025CRLCharles River Laboratories InternationalBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$155.00 ➝ $165.008/1/2025SKINBeauty HealthStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$3.00 ➝ $4.007/9/2025CRLCharles River Laboratories InternationalEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$170.00 ➝ $180.007/9/2025CRLCharles River Laboratories InternationalCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$150.00 ➝ $200.005/23/2025CRLCharles River Laboratories InternationalRedburn AtlanticSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$188.00 ➝ $182.005/14/2025CRLCharles River Laboratories InternationalCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy5/14/2025CRLCharles River Laboratories InternationalTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$179.00(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBARGraniteShares Gold TrustN/AN/AN/AN/AN/AN/ACRLCharles River Laboratories International$4.05B1.81$21.76 per share6.85$67.80 per share2.20REVBRevelation BiosciencesN/AN/AN/AN/A$27.05 per shareN/ASKINBeauty Health$334.30M0.71$0.06 per share29.89$0.41 per share4.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBARGraniteShares Gold TrustN/AN/A0.00∞N/AN/AN/AN/AN/ACRLCharles River Laboratories International$22.20M-$1.33N/A13.554.74-1.69%15.74%7.09%N/AREVBRevelation Biosciences-$15.04M-$68.61N/AN/AN/AN/A-247.38%-146.49%N/ASKINBeauty Health-$29.10M-$0.41N/AN/AN/A-6.13%-36.17%-2.77%N/ALatest BAR, SKIN, CRL, and REVB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025REVBRevelation Biosciences-$4.46-$7.01-$2.55-$7.01N/AN/A8/7/2025Q2 2025SKINBeauty Health-$0.06$0.03+$0.09$0.03$74.67 million$78.20 million8/6/2025Q2 2025CRLCharles River Laboratories International$2.50$3.12+$0.62$1.06$983.76 million$1.03 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBARGraniteShares Gold TrustN/A0.00%N/AN/AN/ACRLCharles River Laboratories InternationalN/AN/AN/AN/AN/AREVBRevelation BiosciencesN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBARGraniteShares Gold TrustN/AN/AN/ACRLCharles River Laboratories International0.691.361.10REVBRevelation BiosciencesN/A3.603.60SKINBeauty Health12.017.476.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBARGraniteShares Gold TrustN/ACRLCharles River Laboratories International98.91%REVBRevelation Biosciences12.80%SKINBeauty Health93.26%Insider OwnershipCompanyInsider OwnershipBARGraniteShares Gold TrustN/ACRLCharles River Laboratories International1.30%REVBRevelation Biosciences2.30%SKINBeauty Health41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBARGraniteShares Gold Trust2,02134.10 millionN/ANot OptionableCRLCharles River Laboratories International20,10049.21 million48.57 millionOptionableREVBRevelation Biosciences101.53 million1.50 millionNot OptionableSKINBeauty Health1,030125.99 million74.34 millionOptionableBAR, SKIN, CRL, and REVB HeadlinesRecent News About These CompaniesWhat Expired Makeup Is Really Doing to Your Eyes and SkinAugust 10 at 11:59 AM | msn.comBeauty Health (NASDAQ:SKIN) Upgraded by Wall Street Zen to Buy RatingAugust 10 at 3:32 AM | marketbeat.comUse AI for skin care info, not treatment decisions: ExpertAugust 9 at 8:57 PM | dailysabah.comDConfused about skincare? Start with this beginner’s guide for healthier skinAugust 9 at 8:57 PM | cnalifestyle.channelnewsasia.comCBeauty Health (NASDAQ:SKIN) Rating Increased to Buy at Wall Street ZenAugust 9 at 3:37 AM | americanbankingnews.comThe Science Of Perfect Skin: Pour Moi’s Climate-Adaptive Skincare Redefines BeautyAugust 9 at 2:00 AM | usmagazine.comUBeautyHealth (NASDAQ:SKIN) Delivers Impressive Q2, Stock Jumps 18.7%August 9 at 2:00 AM | msn.comBeauty Health raises 2025 sales and EBITDA guidance amid margin gains and innovation pushAugust 9 at 2:00 AM | msn.comThe Beauty Health Company (SKIN) Q2 2025 Earnings Call TranscriptAugust 8 at 2:10 PM | seekingalpha.comBeauty Health (SKIN) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesAugust 7 at 8:30 PM | zacks.comThe Beauty Health Company (SKIN) Surpasses Q2 Earnings and Revenue EstimatesAugust 7 at 8:01 PM | zacks.comBeauty Health (SKIN) Q2 Net Jumps 62%August 7 at 5:39 PM | fool.comWhy your skincare routine might be good for your mental health tooAugust 7 at 8:33 AM | msn.com13 French skincare and beauty brands you can shop without a trip to ParisAugust 7 at 3:32 AM | msn.comBaobab fruit powder: Your secret to glowing skinAugust 7 at 3:32 AM | newsbytesapp.comNHere’s how to create radiant skin from the inside outAugust 5, 2025 | prestigeonline.comPBeauty and skincare lovers will adore this 24-hour coverage skin tintAugust 5, 2025 | rsvplive.ieRThe Key to Glowing Skin? It Might Just Be MatchaAugust 5, 2025 | msn.comMartha Stewart Is Finally Launching a Skin Care BrandAugust 5, 2025 | msn.comAfter Five Years in Development, Martha Stewart Is Launching Her Own Skin Care Line Elm BiosciencesAugust 4, 2025 | msn.comAt 84, Martha Stewart Launches Her First Skin-Care BrandAugust 4, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBuy the Dip on 3 Overlooked Names With Major PotentialBy Nathan Reiff | August 3, 2025View Buy the Dip on 3 Overlooked Names With Major PotentialWhy Byrna Could Be the Top Defense Stock to Watch NowBy Nathan Reiff | July 31, 2025View Why Byrna Could Be the Top Defense Stock to Watch Now3 Materials Stocks Everyone Is Talking About Right NowBy Nathan Reiff | July 30, 2025View 3 Materials Stocks Everyone Is Talking About Right Now3 High-Yield Bargains to Watch in 2025’s Second HalfBy Thomas Hughes | July 17, 2025View 3 High-Yield Bargains to Watch in 2025’s Second HalfNewmont's Financial Strength Sets a High Bar for Gold MinersBy Jeffrey Neal Johnson | August 1, 2025View Newmont's Financial Strength Sets a High Bar for Gold MinersBAR, SKIN, CRL, and REVB Company DescriptionsGraniteShares Gold Trust NYSEARCA:BAR$33.51 -0.02 (-0.06%) Closing price 08/8/2025 04:10 PM EasternExtended Trading$33.51 0.00 (0.00%) As of 08/8/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The GraniteShares Gold Trust (BAR) is an exchange-traded fund that is based on the LBMA Gold Price index. The fund tracks the gold spot price, less trust expenses and liabilities, using physically held gold stored and secured in vaults in London. BAR was launched on Aug 31, 2017 and is managed by GraniteShares.Charles River Laboratories International NYSE:CRL$149.07 -0.71 (-0.47%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$150.82 +1.75 (+1.18%) As of 08/8/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.Revelation Biosciences NASDAQ:REVB$2.38 -0.17 (-6.67%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.44 +0.06 (+2.48%) As of 08/8/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.Beauty Health NASDAQ:SKIN$1.89 +0.30 (+18.87%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.04 +0.16 (+8.20%) As of 08/8/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
